FDA Approves New Products
The FDA has approved two new products, one for feline parasite protection and the other for canine noise aversion.
REVOLUTION PLUS (SELAMECTIN AND SAROLANER TOPICAL SOLUTION; ZOETIS)
The 6-in-1 feline parasite preventive protects against fleas (Ctenocephalides felis), ticks (black-legged or deer ticks [Ixodes scapularis], Gulf Coast ticks [Amblyomma maculatum], and American dog ticks [Dermacentor vari­abilis]), ear mites (Otodectes cynotis), roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme), and heartworms (Dirofilaria immitis). The product can be used in cats and kittens as young as 8 weeks that weigh at least 2.8 lb.
PEXION (IMEPITOIN TABLETS; BOEHRINGER INGELHEIM)
Approved for the treatment of noise aversion in dogs, Pexion is dosed (according to weight) twice daily starting 2 days before an expected noise event and continued through the day of the event. The medication will be provided in 100- and 400-mg scored tablets. Due to “capacity constraints at the manufacturing site," however, Pexion will likely not be available for sale until 2020, according to a Boehringer-Ingelheim spokesperson.
Podcast CE: Using Novel Targeted Treatment for Canine Allergic and Atopic Dermatitis
December 20th 2024Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and atopic dermatitis and react to the availability of a novel JAK inhibitor.
Listen
